Biodimension develops biofabricated human tissue and organoid models and offers a portfolio including BioDEpi, BioDFT, BioDPigma, a Pan-Cancer Tumour Microenvironment Biobank, and a Bioassay-as-a-Service (BaaS) platform for research, safety assessment, and drug discovery. The company works with pharmaceutical firms, biotech companies, research institutions, and contract research organizations, and has collaborations across India and Singapore. Biodimension plans to expand its oncology research offerings, scale its BaaS platform, and enter additional international markets such as Southeast Asia. The recent Rs 8 crore funding led by IAN Angel Fund will be used to accelerate product development, expand lab infrastructure, and strengthen scientific and commercial teams to support commercialization domestically and overseas. The company was founded by Manojkumar S., Ranjith Kumar Velusamy, and Pradeep Arunachalam and is based in Bengaluru.

Total raised

$1M

Funding rounds

1

Latest round

Equity

Latest activity

Jun 2026